Clinical Trial Update: Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

View source ↗

Summary

This clinical trial update examines cisplatin-induced cochlear and vestibular damage, including hearing loss, in patients with head and neck squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hearing Loss
• Vestibular Disease

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Simon Jäger | Conditions: Ototoxic Hearing Loss, Ototoxicity, Drug-Induced | Status: NOT_YET_RECRUITING